Alzheimer and Dementias_BIO339_FS24_upload

Alzheimer’s Disease Overview

  • Alzheimer’s disease is a progressive brain disorder that slowly destroys memory and thinking skills.

  • It is the most common form of dementia, contributing to 60-70% of cases.

  • Symptoms typically appear after age 60, but it is not considered a normal part of aging.

Historical Context

Early Documentation

  • In the late 1890s, Auguste Deter, a woman in Germany, begins experiencing memory loss and cognitive decline.

  • These symptoms lead to her admission to a mental institution, highlighting the early case of Alzheimer’s disease.

Alois Alzheimer

  • Alois Alzheimer, a clinical psychiatrist and neuroanatomist, became involved with Auguste’s case post her admission in 1901.

  • He conducted interviews and cognitive tests to understand her decline. Auguste exhibited confusion and disorientation during these assessments.

  • On November 3, 1906, he presented findings at a psychiatric conference, detailing the disease process observed in Deter.

Key Features of Alzheimer’s Disease

Neuroanatomical Changes

  • Alzheimer’s disease is marked by two primary pathological features:

    • Beta-Amyloid Plaques: Abnormal clumps of protein that accumulate outside nerve cells.

    • Neurofibrillary Tangles: Twisted fibers of protein build-up inside nerve cells disrupting their function.

Progression of Disease

  • The disease progresses through identifiable stages:

    • Preclinical Stage: Early signs start in the entorhinal cortex; changes can occur 10-20 years prior to symptomatic onset.

    • Mild to Moderate Stage: Increased memory loss, confusion, and practical difficulties manifest as the cerebral cortex declines.

    • Severe Stage: Marked shrinkage of the brain and total dependence on caregivers; severe symptoms include weight loss and infection risk.

Alzheimer's Disease Statistics

  • Approximately 4.5 million people in the U.S. currently have Alzheimer’s.

  • The disease doubles in prevalence approximately every five years after age 65.

  • Estimated life expectancy post-diagnosis is 8 to 10 years, but this may vary.

Difference Between Alzheimer’s Disease and Dementia

  • Alzheimer’s disease is a specific type of dementia. Dementia itself refers to a range of symptoms affecting memory and cognitive ability.

  • Other types of dementia include Lewy body dementia, vascular dementia, and frontotemporal dementia.

Brain Anatomy Relevant to Alzheimer’s Disease

Brain Structure and Function

  • The adult human brain weighs about 3 pounds and contains approximately 86 billion neurons.

  • Major areas affected by Alzheimer’s include:

    • Cerebral Hemispheres: Responsible for sensory processing and voluntary movement.

    • Cerebellum: Coordinates balance and movement.

    • Brain Stem: Controls basic autonomic functions.

    • Hippocampus: Critical for memory formation.

Impact on Neurons

  • Neurons must effectively communicate and repair themselves for proper function. Alzheimer’s disrupts these processes, leading to neuron death and cognitive decline.

Research and Treatment

Diagnosis Tools

  • Alzheimer’s diagnosis includes patient history, neurological exams, lab tests, and imaging techniques (CT, MRI).

  • Early diagnosis can lead to better management and planning for the future for patients and families.

Treatment Approaches

  • Currently, there are no cures, but some medications such as Donepezil and Memantine can help manage symptoms.

  • Research is ongoing into the causes of Alzheimer’s, including genetic factors and lifestyle influences.

Genetic Factors

  • Genetic predispositions for Alzheimer’s include mutations in specific genes responsible for familial forms of early-onset Alzheimer’s. The APOE ε4 allele is a significant genetic risk factor for late-onset Alzheimer’s.

Future Directions

  • Recent research focuses on identifying effective treatments and understanding the underlying biology of Alzheimer’s disease to develop disease-modifying therapies.